SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-006244
Filing Date
2017-04-10
Accepted
2017-04-10 08:02:19
Documents
4
Period of Report
2017-04-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mstx-8k_20170407.htm 8-K 41008
2 EX-99.1 mstx-ex991_6.htm EX-99.1 27461
3 GRAPHIC g201704071738470033689.jpg GRAPHIC 4304
4 GRAPHIC g201704071738470053690.jpg GRAPHIC 5469
  Complete submission text file 0001564590-17-006244.txt   83770
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130 8585520866
Mast Therapeutics, Inc. (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32157 | Film No.: 17751678
SIC: 2834 Pharmaceutical Preparations